Neurobiological mechanisms of electroconvulsive therapy for depression: Insights into hippocampal volumetric increases from clinical and preclinical studies

Yoshifumi Abe,Vera J. Erchinger,Olga Therese Ousdal,Leif Oltedal,Kenji F. Tanaka,Akihiro Takamiya

DOI: https://doi.org/10.1111/jnc.16054

2024-01-20

Journal of Neurochemistry

Abstract:Clinical MRI studies have consistently shown an increased volume of the hippocampus following electroconvulsive therapy (ECT) in severe, pharmacotherapy‐resistant depression. However, the working mechanism of ECT for depression remains to be elucidated. This narrative review brings together evidence from animal models and human studies, discussing the clinical implications and the specific histological significance of the hippocampal volumetric increases. We also explore the importance of translation research that integrates human and animal models, as well as future directions needed to understand the biological mechanisms underlying ECT. Depression is a highly prevalent and disabling psychiatric disorder. The hippocampus, which plays a central role in mood regulation and memory, has received considerable attention in depression research. Electroconvulsive therapy (ECT) is the most effective treatment for severe pharmacotherapy‐resistant depression. Although the working mechanism of ECT remains unclear, recent magnetic resonance imaging (MRI) studies have consistently reported increased hippocampal volumes following ECT. The clinical implications of these volumetric increases and the specific cellular and molecular significance are not yet fully understood. This narrative review brings together evidence from animal models and human studies to provide a detailed examination of hippocampal volumetric increases following ECT. In particular, our preclinical MRI research using a mouse model is consistent with human findings, demonstrating a marked increase in hippocampal volume following ECT. Notable changes were observed in the ventral hippocampal CA1 region, including dendritic growth and increased synaptic density at excitatory synapses. Interestingly, inhibition of neurogenesis did not affect the ECT‐related hippocampal volumetric increases detected on MRI. However, it remains unclear whether these histological and volumetric changes would be correlated with the clinical effect of ECT. Hence, future research on the relationships between cellular changes, ECT‐related brain volumetric changes, and antidepressant effect could benefit from a bidirectional translational approach that integrates human and animal models. Such translational research may provide important insights into the mechanisms and potential biomarkers associated with ECT‐induced hippocampal volumetric changes, thereby advancing our understanding of ECT for the treatment of depression.

biochemistry & molecular biology,neurosciences